Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001–2016)
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Kiely, Belinda E.
Lord, Sarah J.
Lu, Christine Y.
Ward, Robyn L.
Funding for this research was provided by:
Cancer Australia (1050648)
National Health and Medical Research Council (1094325, 1060407)
National Breast Cancer Foundation (no award number)
Sydney Catalyst (no award number)
unspecified valid from 2018-05-07